Abstract
1,2-Bis(2-pyridyl)ethane-1,2-dione was allowed to react with different phosphorus nucleophiles. Treatment of the 1,2-bis(2-pyridyl)ethane-1,2-dione with the active phosphacumulene ylides, (N-phenylimino)-, and (2-oxovinylidene)-triphenylphosphorane afforded the phosphanylidene–cyclobutylidenes. On the other hand, its reaction with hexaphenylcarbodiphosphorane gave the oxaphosphetane and the phosphanylidene analogs. Next, the pyridazinone was obtained from the reaction of dipyridine hydrazone and the aminovinylidene triphenylphosphorane. Oxathiaphosphetanes were generated from the reaction of Lawesson's and Japanese reagents with the dipyridyl ethanedione. Some of the new compounds were tested on the human promyelocytic leukemia (HL-60), lung cancer (A549), breast adenocarcinoma (T-47D), and human colon cancer cells (LoVo) in comparison with the known anticancer drugs cisplatin (CIS) and doxorubicin (DOX). Compound 6 has the highest activity against all the tested cancer cells.

This publication has 34 references indexed in Scilit: